Study of Time-restricted Eating on Weight Loss.
TREAT
1 other identifier
interventional
137
1 country
1
Brief Summary
This is a randomized controlled trial studying the effects of time-restricted eating (TRE) on weight loss in obese humans. Obesity is the number one risk factor for type 2 Diabetes Mellitus (T2DM), and numerous studies demonstrate that weight loss is an effective strategy to prevent T2DM and improve the metabolic health of people diagnosed with T2DM. Unfortunately, classical calorie restriction diets often fail to produce long-term weight loss due to low compliance, reduced resting metabolic rate (RMR), and other factors. Therefore, novel dieting techniques must be explored in order to successfully treat obesity and prevent T2DM. Studies in mice provide compelling evidence that feeding/fasting cycles can be altered to produce beneficial effects on weight loss and metabolic health markers in the absence of calorie restriction. Limited research in human subjects suggests that this feeding paradigm may translate to human health as well, however, more research needs to be done in order to confirm this hypothesis. This study will determine if TRE can lead to weight loss in obese human subjects. Secondary outcomes include changes in body composition, HOMA-IR, hormonal and biochemical serum markers, RMR, and total energy expenditure (TEE).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Jul 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2017
CompletedFirst Posted
Study publicly available on registry
January 8, 2018
CompletedStudy Start
First participant enrolled
July 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2020
CompletedMarch 3, 2020
February 1, 2020
1.2 years
December 20, 2017
February 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight Loss
Measure changes in weight during the 12 week study
Daily for 12 weeks
Secondary Outcomes (7)
Fat loss
Measured twice: Once at study start and once 12 weeks later
Changes in lean mass
Measured twice: Once at study start and once 12 weeks later
Fasting insulin levels
Measured twice: Once at study start and once 12 weeks later
Resting metabolic rate
Measured twice: Once at study start and once 12 weeks later
Total energy expenditure
Measured twice: Once at study start and once 12 weeks later
- +2 more secondary outcomes
Study Arms (2)
Time-restricted eating plan
EXPERIMENTALParticipants in this group will be instructed to fast every day from 8pm until 12pm the following day. From 12pm until 8pm, participants can eat and drink whatever they want. During fasting hours, participants can drink water and black coffee.
Consistent Meal Timing Plan
ACTIVE COMPARATORParticipants in this group will be instructed to eat three daily meals during specified eating times. Their first meal will be between 7am-11am. Second meal between 11am and 3pm, and third meal between 4pm-10pm. Participants will be encouraged to eat small snacks if needed so that they can eat their next meal during the specified window.
Interventions
Research team will prescribe an eating plan for the participant to follow for the 12 week study. The eating plan will consist of eating during a specified 8 hour window and fasting for the remaining 16 hours of the day.
Research team will prescribe an eating plan for the participant to follow for the 12 week study.The eating plan will consist of eating three structured meals each day during three specified meal windows.
Eligibility Criteria
You may qualify if:
- BMI between 30-40 kg/m2
- Participants must regularly consume breakfast (at least 5 days per week)
- Must speak, read, and comprehend English
- Access to reliable internet and/or wifi
- Must have a valid email address and phone number
- Must have a cellular phone with data plan
You may not qualify if:
- HIV or immunocompromised
- Current or past cancer diagnosis
- Pregnant, breastfeeding, or planned pregnancy in next 6 months
- Beginning or ending hormonal contraception in next 6 months
- Current diagnosis of type or type 2 diabetes
- Currently taking glucose-lowering drugs, statins, or oral steroids
- History of gastric bypass surgery or any other weight-loss surgery
- History of anorexia or bulimia
- Frequent travel across time zones or unusual work hours
- Unable to fast for prolonged periods due to medical condition
- Unable to stand for several minutes without aid
- Cannot lie down on cushioned table for 30 minutes
- No internal metal artifacts that would alter body composition
- Unable to travel to UCSF for in-person testing
- Requires translator services
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSF Medical Center
San Francisco, California, 94143, United States
Related Publications (2)
Wong MC, Bennett JP, Leong LT, Tian IY, Liu YE, Kelly NN, McCarthy C, Wong JMW, Ebbeling CB, Ludwig DS, Irving BA, Scott MC, Stampley J, Davis B, Johannsen N, Matthews R, Vincellette C, Garber AK, Maskarinec G, Weiss E, Rood J, Varanoske AN, Pasiakos SM, Heymsfield SB, Shepherd JA. Monitoring body composition change for intervention studies with advancing 3D optical imaging technology in comparison to dual-energy X-ray absorptiometry. Am J Clin Nutr. 2023 Apr;117(4):802-813. doi: 10.1016/j.ajcnut.2023.02.006. Epub 2023 Feb 14.
PMID: 36796647DERIVEDLowe DA, Wu N, Rohdin-Bibby L, Moore AH, Kelly N, Liu YE, Philip E, Vittinghoff E, Heymsfield SB, Olgin JE, Shepherd JA, Weiss EJ. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Intern Med. 2020 Nov 1;180(11):1491-1499. doi: 10.1001/jamainternmed.2020.4153.
PMID: 32986097DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ethan J Weiss, MD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2017
First Posted
January 8, 2018
Study Start
July 30, 2018
Primary Completion
October 23, 2019
Study Completion
January 10, 2020
Last Updated
March 3, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share